The Food and Drug Administration (FDA) has approved the immunotherapy drug pembrolizumab (Keytruda) to treat some patients with advanced esophageal cancer. The treatment was approved for patients with locally advanced or metastatic squamous cell carcinoma of the esophagus (ESCC) […]

Finding new ways to help people quit smoking continues to be a challenge. In a recent study, researchers tried a unique approach: training pediatricians’ offices to provide smoking cessation treatment to parents […]

Last spring, at the end of his sophomore year of college, Jace Ward developed double vision in his left eye. He thought the problem might have been related to a recent car […]

Early detection of cancer greatly increases the likelihood of successful treatment. Despite this, the traditional steps in obtaining a diagnosis are time consuming. Patients will typically need to undergo a series of […]

The first therapies that target mutated forms of the EGFR protein were approved for use in people with non-small cell lung cancer (NSCLC) more than 15 years ago. Updated results from a large clinical trial now show […]

In women with ovarian cancer that has come back after initial treatment, physicians recommend additional surgery in some cases to remove as much of the cancer as possible before starting chemotherapy treatment […]

New findings from a clinical trial show that treatment with the immunotherapy drug blinatumomab is superior to standard chemotherapy for children and young adults with high- or intermediate-risk B-cell acute lymphoblastic leukemia […]

In some people with non-Hodgkin lymphoma (NHL), treating a single tumor with a mix of cancer therapies can help to shrink, or eliminate, tumors in other parts of the body, findings from […]